Naveen Anand Seecheran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Naveen Anand Seecheran has a total of 220 co-authors. Here are the top co-authors by number of shared publications:
Rajeev Seecheran
University of New Mexico Medical Center
40 shared publicationsValmiki Seecheran
North Central Regional Health Authority
40 shared publicationsPriya Ramcharan
North Central Regional Health Authority
22 shared publicationsStanley Giddings
Department of Clinical Medical Sciences, The University of the West Indies, St. Augustine, Trinidad and Tobago
16 shared publicationsAntonio Tello-Montoliu
Cardiology Division, Universidad de Murcia, Murcia, Spain
15 shared publicationsSangeeta Persad
North Central Regional Health Authority, Mount Hope, Trinidad and Tobago
15 shared publications
Latest Publications
- Open Access
- 24 October 2026
- Published by SAGE Publications in Journal of Investigative Medicine High Impact Case Reports
- Vol. 14
Suspected Kearns-Sayre-associated Tachy-Brady Syndrome
Kearns–Sayre syndrome (KSS) is a rare mitochondrial disorder characterized by a triad of onset before the age of 20 years, chronic progressive external ophthalmoplegia (CPEO), and pigmentary retinopathy, together with systemic features such as cardiac conduction disease. Deletions or mutations in mitochondrial deoxyribonucleic acid (mtDNA) can disrupt cellular function, affecting the myocardial intercalated discs, resulting in arrhythmias. We hereby present the case of a 65-year-old Caucasian male of German origin with a pre-existing diagnosis of KSS, who presented with tachy-brady syndrome (TBS) with paroxysmal atrial fibrillation (PAF) and sinus bradycardia (SB) with a first-degree atrioventricular block (AVB). He was treated with guideline-directed medical therapy (GDMT) for heart failure with preserved ejection fraction (HFpEF) and direct oral anticoagulation (DOAC) for PAF. He deferred device therapy despite extensive counseling for sudden cardiac death (SCD) associated with KSS. Given the relative paucity of conventional risk factors, suspected Kearns-Sayre-associated tachy-brady syndrome (TBS) was deemed the likely diagnosis.
- 24 October 2026
- Published by SAGE Publications in Journal of Investigative Medicine High Impact Case Reports
- Vol. 14
Open AccessSuspected Kearns-Sayre-associated Tachy-Brady Syndrome
Kearns–Sayre syndrome (KSS) is a rare mitochondrial disorder characterized by a triad of onset before the age of 20 years, chronic progressive external ophthalmoplegia (CPEO), and pigmentary retinopathy, together with systemic features such as cardiac conduction disease. Deletions or mutations in mitochondrial deoxyribonucleic acid (mtDNA) can disrupt cellular function, affecting the myocardial intercalated discs, resulting in arrhythmias. We hereby present the case of a 65-year-old Caucasian male of German origin with a pre-existing diagnosis of KSS, who presented with tachy-brady syndrome (TBS) with paroxysmal atrial fibrillation (PAF) and sinus bradycardia (SB) with a first-degree atrioventricular block (AVB). He was treated with guideline-directed medical therapy (GDMT) for heart failure with preserved ejection fraction (HFpEF) and direct oral anticoagulation (DOAC) for PAF. He deferred device therapy despite extensive counseling for sudden cardiac death (SCD) associated with KSS. Given the relative paucity of conventional risk factors, suspected Kearns-Sayre-associated tachy-brady syndrome (TBS) was deemed the likely diagnosis.
- Open Access
- 3 August 2026
- Published by SAGE Publications in Journal of Investigative Medicine High Impact Case Reports
- Vol. 14
Suspected Denosumab-Associated Acute Coronary Syndrome
Denosumab, a monoclonal antibody (mAb) targeting receptor activator of nuclear factor-κB ligand (RANKL), is commonly used in managing metabolic bone diseases and giant cell tumors (GCTs) of bone. Growing evidence suggests that RANKL inhibition may influence cardiovascular health by impacting endothelial function, inflammatory pathways, vascular smooth muscle cell behavior, and systemic calcium regulation. We report a case of a 48-year-old Caribbean-South Asian man with recurrent GCTs who received three subcutaneous doses of denosumab and soon thereafter developed an anterior ST-elevation acute coronary syndrome (STE-ACS). The patient had no traditional cardiometabolic risk factors. Coronary angiography revealed thrombotic occlusion of the proximal left anterior descending artery (LAD), which was successfully treated with primary percutaneous coronary intervention (PPCI) and guideline-directed medical therapy (GDMT). Given the lack of modifiable risk factors, a significant family history, and biologically plausible mechanisms linking RANKL inhibition to atherothrombotic events, a denosumab-associated myocardial infarction was considered the most probable cause.
- 3 August 2026
- Published by SAGE Publications in Journal of Investigative Medicine High Impact Case Reports
- Vol. 14
Open AccessSuspected Denosumab-Associated Acute Coronary Syndrome
Denosumab, a monoclonal antibody (mAb) targeting receptor activator of nuclear factor-κB ligand (RANKL), is commonly used in managing metabolic bone diseases and giant cell tumors (GCTs) of bone. Growing evidence suggests that RANKL inhibition may influence cardiovascular health by impacting endothelial function, inflammatory pathways, vascular smooth muscle cell behavior, and systemic calcium regulation. We report a case of a 48-year-old Caribbean-South Asian man with recurrent GCTs who received three subcutaneous doses of denosumab and soon thereafter developed an anterior ST-elevation acute coronary syndrome (STE-ACS). The patient had no traditional cardiometabolic risk factors. Coronary angiography revealed thrombotic occlusion of the proximal left anterior descending artery (LAD), which was successfully treated with primary percutaneous coronary intervention (PPCI) and guideline-directed medical therapy (GDMT). Given the lack of modifiable risk factors, a significant family history, and biologically plausible mechanisms linking RANKL inhibition to atherothrombotic events, a denosumab-associated myocardial infarction was considered the most probable cause.
- Open Access
- 12 June 2026
- Published by Springer Nature in BMC Neurology
- Vol. 26 (1)
Stroke risk factors and outcomes in Trinidad and Tobago: the START study
This study aimed to assess the risk factors, associations and outcomes of stroke at an academic tertiary medical center in Trinidad and Tobago. This cross-
- 12 June 2026
- Published by Springer Nature in BMC Neurology
- Vol. 26 (1)
Open AccessStroke risk factors and outcomes in Trinidad and Tobago: the START study
This study aimed to assess the risk factors, associations and outcomes of stroke at an academic tertiary medical center in Trinidad and Tobago. This cross-
- Open Access
- 20 May 2026
- Published by SAGE Publications in Journal of Investigative Medicine High Impact Case Reports
- Vol. 14
Guillain-Barré Syndrome Presenting With New-Onset Heart Failure
Guillain-Barré syndrome (GBS) is an acute immune-mediated polyneuropathy that can involve the autonomic nervous system, leading to hemodynamic instability. While transient arrhythmias are typically observed, the occurrence of acute heart failure (AHF) within the GBS spectrum is exceedingly rare. We report the case of a previously healthy 61-year-old Caribbean South-Asian male who developed intractable left ventricular dysfunction (LVD) and cardiogenic shock (CS) after returning from a one-month vacation in Canada, from which he ultimately succumbed despite aggressive guideline-directed medical therapy (GDMT) and high-dose intravenous immunoglobulin (IVIG). Notably, the patient’s younger brother predeceased him (25 years) from a suspected GBS-related complication, while his niece also survived a protracted GBS-hospitalization when she was very young (4 years). This case highlights that acute cardiomyopathy (CMP) may be a rare but catastrophic sequela of GBS, underscoring the importance of early recognition and intensive supportive care. The robust familial link also suggests a potential genetic susceptibility to GBS, warranting heightened vigilance and further research.
- 20 May 2026
- Published by SAGE Publications in Journal of Investigative Medicine High Impact Case Reports
- Vol. 14
Open AccessGuillain-Barré Syndrome Presenting With New-Onset Heart Failure
Guillain-Barré syndrome (GBS) is an acute immune-mediated polyneuropathy that can involve the autonomic nervous system, leading to hemodynamic instability. While transient arrhythmias are typically observed, the occurrence of acute heart failure (AHF) within the GBS spectrum is exceedingly rare. We report the case of a previously healthy 61-year-old Caribbean South-Asian male who developed intractable left ventricular dysfunction (LVD) and cardiogenic shock (CS) after returning from a one-month vacation in Canada, from which he ultimately succumbed despite aggressive guideline-directed medical therapy (GDMT) and high-dose intravenous immunoglobulin (IVIG). Notably, the patient’s younger brother predeceased him (25 years) from a suspected GBS-related complication, while his niece also survived a protracted GBS-hospitalization when she was very young (4 years). This case highlights that acute cardiomyopathy (CMP) may be a rare but catastrophic sequela of GBS, underscoring the importance of early recognition and intensive supportive care. The robust familial link also suggests a potential genetic susceptibility to GBS, warranting heightened vigilance and further research.
- Open Access
- 28 March 2026
- Published by SAGE Publications in Journal of Investigative Medicine High Impact Case Reports
- Vol. 14
Suspected Cannabis-Induced Acute Coronary Syndrome and Advanced Heart block
We describe a 35-year-old Caribbean-Black male patient with a significant cannabis history who presented with an inferior ST-segment-elevation acute coronary syndrome (STE-ACS), with advanced heart block during active, ongoing cannabis consumption. During primary percutaneous coronary intervention, cineangiography revealed substantial thrombus burden in the first acute marginal branch of the right coronary artery. He successfully underwent aspiration thrombectomy with subsequent angioplasty with a drug-coated balloon and guideline-directed medical therapy, including direct oral anticoagulation. The clinician should be cognizant of the association between ACS and both acute and chronic cannabis consumption.
- 28 March 2026
- Published by SAGE Publications in Journal of Investigative Medicine High Impact Case Reports
- Vol. 14
Open AccessSuspected Cannabis-Induced Acute Coronary Syndrome and Advanced Heart block
We describe a 35-year-old Caribbean-Black male patient with a significant cannabis history who presented with an inferior ST-segment-elevation acute coronary syndrome (STE-ACS), with advanced heart block during active, ongoing cannabis consumption. During primary percutaneous coronary intervention, cineangiography revealed substantial thrombus burden in the first acute marginal branch of the right coronary artery. He successfully underwent aspiration thrombectomy with subsequent angioplasty with a drug-coated balloon and guideline-directed medical therapy, including direct oral anticoagulation. The clinician should be cognizant of the association between ACS and both acute and chronic cannabis consumption.
- 23 February 2026
- Published by Taylor & Francis in Medical Teacher
- Vol. 48 (9) , 1-9
Comparing performance and integrity of proctored physical, unproctored online, and proctored online MBBS exams
- 23 February 2026
- Published by Taylor & Francis in Medical Teacher
- Vol. 48 (9) , 1-9
Comparing performance and integrity of proctored physical, unproctored online, and proctored online MBBS exams
- Open Access
- 28 January 2026
- Published by SAGE Publications in Journal of Investigative Medicine High Impact Case Reports
- Vol. 14
Stanford Type B Aortic Dissection in an Adult Patient With Unrepaired Coarctation of the Aorta
Coarctation of the aorta (CoA) is a congenital narrowing typically detected in childhood; survival into adulthood without repair is uncommon. Aortic dissection (AD) is an exceedingly rare complication in this specific context, particularly involving the descending aorta. We describe a case of a 46-year-old Caribbean-Black male with a medical history of chronic hypertension (HTN) who presented with unstable angina and hypertensive crisis. Emergent computed tomography angiography revealed critical proximal descending CoA with poststenotic dilatation and an acute Stanford type B AD. He was initially stabilized on guideline-directed medical therapy, and while definitive surgical repair was recommended, the patient declined. This exceedingly rare case of type B AD complicating unrepaired CoA underscores the importance of recognizing congenital aortic disease as a cause of refractory HTN in adults. Additionally, it highlights the need for continued vigilance for long-term complications in adults with congenital heart disease.
- 28 January 2026
- Published by SAGE Publications in Journal of Investigative Medicine High Impact Case Reports
- Vol. 14
Open AccessStanford Type B Aortic Dissection in an Adult Patient With Unrepaired Coarctation of the Aorta
Coarctation of the aorta (CoA) is a congenital narrowing typically detected in childhood; survival into adulthood without repair is uncommon. Aortic dissection (AD) is an exceedingly rare complication in this specific context, particularly involving the descending aorta. We describe a case of a 46-year-old Caribbean-Black male with a medical history of chronic hypertension (HTN) who presented with unstable angina and hypertensive crisis. Emergent computed tomography angiography revealed critical proximal descending CoA with poststenotic dilatation and an acute Stanford type B AD. He was initially stabilized on guideline-directed medical therapy, and while definitive surgical repair was recommended, the patient declined. This exceedingly rare case of type B AD complicating unrepaired CoA underscores the importance of recognizing congenital aortic disease as a cause of refractory HTN in adults. Additionally, it highlights the need for continued vigilance for long-term complications in adults with congenital heart disease.
- Open Access
- 13 November 2025
- Published by Springer Nature in Cureus
- Vol. 17 (11)
Suspected Pulmonary Embolism-Associated Advanced Heart Block
We describe a 35-year-old Caribbean-Black male smoker with suspected pulmonary embolism (PE)-associated advanced heart block, which was both confirmed with computed tomography pulmonary angiography (CTPA) and inpatient telemetry. The patient received guideline-directed medical therapy for PE, including direct oral anticoagulation (DOAC), and underwent permanent dual-chamber pacemaker (DCPM) implantation for complete heart block (CHB). The clinician should consider atypical etiologies such as PE in young adults presenting with advanced heart block.
- 13 November 2025
- Published by Springer Nature in Cureus
- Vol. 17 (11)
Open AccessSuspected Pulmonary Embolism-Associated Advanced Heart Block
We describe a 35-year-old Caribbean-Black male smoker with suspected pulmonary embolism (PE)-associated advanced heart block, which was both confirmed with computed tomography pulmonary angiography (CTPA) and inpatient telemetry. The patient received guideline-directed medical therapy for PE, including direct oral anticoagulation (DOAC), and underwent permanent dual-chamber pacemaker (DCPM) implantation for complete heart block (CHB). The clinician should consider atypical etiologies such as PE in young adults presenting with advanced heart block.
- Open Access
- 28 September 2025
- Published by SAGE Publications in Journal of Investigative Medicine High Impact Case Reports
- Vol. 13
Relapsing Polychondritis-Associated Myocardial Infarction With Non-Obstructive Coronary Arteries
We describe a 40-year-old South Asian female with relapsing polychondritis-associated myocardial infarction with non-obstructive coronary arteries during an acute flare for which she was successfully managed with guideline-directed medical therapy. The clinician should be cognizant of this rare association, especially in patients who present with acute coronary syndromes and chronic, pre-existing autoimmune syndromes.
- 28 September 2025
- Published by SAGE Publications in Journal of Investigative Medicine High Impact Case Reports
- Vol. 13
Open AccessRelapsing Polychondritis-Associated Myocardial Infarction With Non-Obstructive Coronary Arteries
We describe a 40-year-old South Asian female with relapsing polychondritis-associated myocardial infarction with non-obstructive coronary arteries during an acute flare for which she was successfully managed with guideline-directed medical therapy. The clinician should be cognizant of this rare association, especially in patients who present with acute coronary syndromes and chronic, pre-existing autoimmune syndromes.
- Open Access
- 14 August 2025
- Vol. 17 (8) , e90057
ST-Segment-Elevation Acute Coronary Syndrome in a Patient With a Superdominant Right Coronary Artery and a Coincident Absent Left Circumflex Artery
We describe a case of a 42-year-old Caribbean South Asian male with no conventional cardiovascular risk factors who presented with an inferolateral ST-segment-elevation acute coronary syndrome (STE-ACS) with thrombolysis in myocardial infarction (TIMI) thrombus grade 4 in a superdominant right coronary artery (sdRCA) and absent left circumflex (LCx) artery. The healthcare team should be cognizant of rare coronary artery anomalies (CAAs), their pathophysiology, and the individualized management strategies for these related ACS.
- 14 August 2025
- Vol. 17 (8) , e90057
Open AccessST-Segment-Elevation Acute Coronary Syndrome in a Patient With a Superdominant Right Coronary Artery and a Coincident Absent Left Circumflex Artery
We describe a case of a 42-year-old Caribbean South Asian male with no conventional cardiovascular risk factors who presented with an inferolateral ST-segment-elevation acute coronary syndrome (STE-ACS) with thrombolysis in myocardial infarction (TIMI) thrombus grade 4 in a superdominant right coronary artery (sdRCA) and absent left circumflex (LCx) artery. The healthcare team should be cognizant of rare coronary artery anomalies (CAAs), their pathophysiology, and the individualized management strategies for these related ACS.